ADAR and chronic myelogenous leukemia, BCR-ABL1 positive: Upregulation of MDM2 in BC CML has been known for a long time,45 and it has recently been linked to ADAR1‐mediated A‐to‐I RNA editing of the 3′‐UTR of MDM2, enabling MDM2 to evade miRNA targeting.46